Knoll Mavik once-daily ACE inhibitor will launch in June following April 26 approval.
Executive Summary
KNOLL MAVIK ACE INHIBITOR WILL LAUNCH IN JUNE following approval April 26. Mavik (trandolapril) had been "approvable" at FDA since Sept. 25 for the treatment of hypertension. Knoll Pharmaceutical will launch Mavik at 50 [cents] per tablet, according to "coming soon" ads that ran earlier this year ("The Pink Sheet" March 25, T&G-3). Mavik tablets will be priced the same for 1 mg, 2 mg and 4 dosage strengths.